NCT01978015View on ClinicalTrials.gov

Blood-aqueous Barrier Changes After the Use of Timolol and Prostaglandin Analogues Fixed Combination in Pseudophakic Patients With POAG

PHASE4CompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

July 31, 2012

Study Completion Date

January 31, 2013

Conditions
Uveitis, AnteriorCystoid Macular Edema
Interventions
DRUG

travoprost and timolol maleate fixed combination

travoprost 0.004% and timolol maleate 0,5%, 1 eye drop at 8p.m. for 6 months

DRUG

latanoprost and maleate timolol fixed combination

Latanoprost 0.005% and timolol maleate 0,5%, 1 eye drop at 8 p.m for 6 months

DRUG

bimatoprost and timolol maleate fixed combination

bimatoprost0.03% and timolol maleate 0,5%, 1 eye drop at 8 p.m for 6 months

DRUG

dextran and hypromellose

Dextran 70 and hypromellose, lubricant eye drop at 8 a.m and 8 p.m for 6 months

Trial Locations (1)

13083-888

Hospital de Clínicas, UNICAMP, Campinas

All Listed Sponsors
lead

University of Campinas, Brazil

OTHER

NCT01978015 - Blood-aqueous Barrier Changes After the Use of Timolol and Prostaglandin Analogues Fixed Combination in Pseudophakic Patients With POAG | Biotech Hunter | Biotech Hunter